Fabros, Loreta .
HRN: 23-01-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2023
MUPIROCIN 2%, 15G (TUBE)
05/20/2023
05/27/2023
APPLY ON SKIN
As Required
BID
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes